Shilanski & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $584K | Sell |
|
|||||
|
2024
Q2 | $733K | Sell |
|
|||||
|
2024
Q1 | $698K | Buy |
|
|||||
|
2023
Q4 | $527K | Sell |
|
|||||
|
2023
Q3 | $484K | Sell |
|
|||||
|
2023
Q2 | $443K | Buy |
|
|||||
|
2023
Q1 | $430K | Sell |
|
|||||
|
2022
Q4 | $369K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $290K | Buy |
|
|||||
|
2022
Q1 | $287K | Buy |
|
|||||
|
2021
Q4 | $251K | Buy |
|